IL62133A - Peptide derivatives of pyranosamine,their manufacture and pharmaceutical compositions containing them - Google Patents

Peptide derivatives of pyranosamine,their manufacture and pharmaceutical compositions containing them

Info

Publication number
IL62133A
IL62133A IL62133A IL6213381A IL62133A IL 62133 A IL62133 A IL 62133A IL 62133 A IL62133 A IL 62133A IL 6213381 A IL6213381 A IL 6213381A IL 62133 A IL62133 A IL 62133A
Authority
IL
Israel
Prior art keywords
formula
pyranosamine
manufacture
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL62133A
Other languages
English (en)
Other versions
IL62133A0 (en
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of IL62133A0 publication Critical patent/IL62133A0/xx
Publication of IL62133A publication Critical patent/IL62133A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • A23K20/147Polymeric derivatives, e.g. peptides or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Steroid Compounds (AREA)
IL62133A 1980-02-15 1981-02-13 Peptide derivatives of pyranosamine,their manufacture and pharmaceutical compositions containing them IL62133A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH126580 1980-02-15

Publications (2)

Publication Number Publication Date
IL62133A0 IL62133A0 (en) 1981-03-31
IL62133A true IL62133A (en) 1985-04-30

Family

ID=4206350

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62133A IL62133A (en) 1980-02-15 1981-02-13 Peptide derivatives of pyranosamine,their manufacture and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US4406889A (no)
EP (1) EP0034347B1 (no)
JP (1) JPS56128794A (no)
KR (3) KR850000077B1 (no)
AT (1) ATE19087T1 (no)
AU (1) AU544636B2 (no)
CA (1) CA1181393A (no)
DD (1) DD159341A5 (no)
DE (1) DE3174293D1 (no)
DK (1) DK65281A (no)
ES (1) ES8202031A1 (no)
FI (1) FI72733C (no)
GB (1) GB2070619B (no)
GR (1) GR73555B (no)
HU (1) HU194910B (no)
IE (1) IE50899B1 (no)
IL (1) IL62133A (no)
NO (1) NO151325C (no)
NZ (1) NZ196261A (no)
PT (1) PT72500B (no)
ZA (1) ZA81969B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57144225A (en) * 1981-03-04 1982-09-06 Tadao Kokubu Antigenetic preparation for treating nonspecific allergic diseases and its preparation
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
DE3465087D1 (en) * 1983-03-04 1987-09-03 Merck & Co Inc Immunostimulatory dipeptidyl d-glucose derivatives and methods of preparation
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4631343A (en) * 1983-11-07 1986-12-23 Eli Lilly And Company Cyanopyrazole intermediates
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
PT80531B (de) * 1984-05-29 1987-04-06 Ciba Geigy Ag Verfahren zur herstellung acylerter zuckerderivate
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体
US4640911A (en) * 1985-05-29 1987-02-03 Ciba-Geigy Corporation Acylated sugar derivatives, processes for their manufacture, and their use
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
PT2411521E (pt) 2009-03-25 2015-04-21 Univ Texas Composições para estimulação de resistência imunitária inata de mamíferos contra patogénicos
WO2016044839A2 (en) 2014-09-19 2016-03-24 The Board Of Regents Of The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2019040109A1 (en) 2017-08-21 2019-02-28 Celgene Corporation PROCESSES FOR THE PREPARATION OF (S) -TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2343482A1 (fr) * 1976-03-10 1977-10-07 Anvar La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
JPS5479228A (en) * 1977-12-02 1979-06-25 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
CA1185237A (en) * 1979-02-28 1985-04-09 Yuichi Yamamura 6-deoxyglucosamine-peptide derivatives, their production and use

Also Published As

Publication number Publication date
DD159341A5 (de) 1983-03-02
DE3174293D1 (en) 1986-05-15
NO810500L (no) 1981-08-17
ES499420A0 (es) 1982-01-01
AU6728481A (en) 1981-08-20
PT72500A (en) 1981-03-01
NO151325C (no) 1985-03-20
KR850000064B1 (ko) 1985-02-15
ZA81969B (en) 1982-09-29
GR73555B (no) 1984-03-15
KR850000077B1 (ko) 1985-02-18
GB2070619B (en) 1983-07-06
HU194910B (en) 1988-03-28
PT72500B (en) 1982-02-05
EP0034347B1 (de) 1986-04-09
FI810461L (fi) 1981-08-16
AU544636B2 (en) 1985-06-06
US4406889A (en) 1983-09-27
ATE19087T1 (de) 1986-04-15
EP0034347A3 (en) 1981-11-18
CA1181393A (en) 1985-01-22
EP0034347A2 (de) 1981-08-26
GB2070619A (en) 1981-09-09
JPS56128794A (en) 1981-10-08
FI72733B (fi) 1987-03-31
IE810296L (en) 1981-08-15
DK65281A (da) 1981-08-16
KR830005257A (ko) 1983-08-03
FI72733C (fi) 1987-07-10
IL62133A0 (en) 1981-03-31
NO151325B (no) 1984-12-10
ES8202031A1 (es) 1982-01-01
IE50899B1 (en) 1986-08-06
KR850000063B1 (ko) 1985-02-15
NZ196261A (en) 1984-05-31

Similar Documents

Publication Publication Date Title
IL62133A (en) Peptide derivatives of pyranosamine,their manufacture and pharmaceutical compositions containing them
IL87908A0 (en) Immunomodulatory azaspiranes
HUT37657A (en) Process for producing new polypeptides of alpha-amilase-inhibiting activity and pharmaceutical compositions containing them
IL86133A0 (en) Beta-d-phenylthioxylosides,their preparation and pharmaceutical compositions containing them
IL62198A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
DE3170623D1 (en) Guanidine derivatives and pharmaceutical compositions containing them
DE3378413D1 (en) Spiro-2-aza-alkane-3-carbonitriles, process for their preparation and their use
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
IL73900A (en) Protection of keratinous material from insects by treatment with pyridyloxytrifluoromethane sulfonanilides,certain such novel compounds,their preparation and compositions containing them
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
ES2060029T3 (es) Derivados de acido 6-fluorosiquimico.
DE3362009D1 (en) L-alanyl-d-isoglutaminyl-adamantyl amide, process for its preparation and pharmaceutical compositions containing this compound
SE8302394L (sv) Nya modifierade leror, framstellning derav och terapeutiska kompositioner innehallande dessa
IT8123540A0 (it) Procedimento per la preparazione di composti citostatici e composizioni farmaceutiche contenenti gli stessi.
EP0043976A3 (en) Anti-tumor agent
IL95384A0 (en) 1,3-oxazines,their preparation and pharmaceutical compositions containing them
EP0345719A3 (en) Compounds containing at least three functional ester groups, and process for their preparation
JPS562997A (en) Preparation of aminoglycoside, and novel aminoglycoside